Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
R., Holscher, C
("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced that China's National Medical Products Administration (NMPA) has approved ecnoglutide injection for glycemic control in adults with type 2 diabetes mellitus (T2DM), making it the world's first approved cAMP-biased GLP-1 receptor agonist
We donate 10% of all our profits to veteran-focused charities
Basque, J
Remember, youre not alone in this journey
US$ 23.19
US$ 26.07
US$ 29.35
US$ 21.82
US$ 24.06
US$ 26.28
US$ 25.29
US$ 29.45
US$ 24.81
US$ 27.67
US$ 24.08
US$ 24.00
